Showing results (231-240 of 1,012) with videos related to

Sort By:
Pageof 102
Cancer Research Communications|February 16, 2025
Tumor Cell Plasticity and Stromal Microenvironment Distinguish Papillary and Follicular Growth Patterns in a Mouse Model of BRAFV600E-Induced Thyroid CancerElin Schoultz, Carmen Moccia, Shawn Liang, et al.
Cancer Research Communications|February 21, 2025
Safety and Antitumor Activity of a Novel aCD25 Treg Depleter RG6292 as a Single Agent and in Combination with Atezolizumab in Patients with Solid TumorsValentina Gambardella, Michael Ong, Maria E Rodriguez-Ruiz, et al.
Cancer Research Communications|November 1, 2024
Spatial Context of Immune Checkpoints as Predictors of Overall Survival in Patients with Resectable Colorectal Cancer Independent of Standard Tumor-Node-Metastasis StagesHao Kong, Qingxin Yang, Chunwei Wu, et al.
Cancer Research Communications|September 26, 2025
Initial-Care Medical and Prescription Costs for Incident Metastatic versus Nonmetastatic Colorectal CancerChi M Nguyen, Paul G Yeh, Mai P Nguyen, et al.
Cancer Research Communications|October 2, 2025
Novel Afro-Caribbean Prostate Cancer Model Reveals Ancestry-Specific Drug Vulnerabilities with Therapeutic Implications for Black PatientsSimone Badal, Bor-Jang Hwang, Ashlianne Nelson, et al.
Cancer Research Communications|September 23, 2025
Auranofin Synergizes with Cisplatin in Reducing Tumor Burden of NOTCH-Dependent Ovarian CancerRobert J Lake, Parisa Nikeghbal, Irina V Lagutina, et al.
Cancer Research Communications|December 6, 2023
Combined Inhibition of EZH2 and FGFR is Synergistic in BAP1-deficient Malignant MesotheliomaJitendra Badhai, Nick Landman, Gaurav Kumar Pandey, et al.
Cancer Research Communications|December 5, 2023
A Systems Biology Approach to Understand the Racial Disparities in Colorectal CancerAnnabelle Nwaokorie, Walter Kolch, Dirk Fey
Cancer Research Communications|November 30, 2023
FBXW7-loss Sensitizes Cells to ATR Inhibition Through Induced Mitotic CatastropheSiobhan O'Brien, Tajinder Ubhi, Lucie Wolf, et al.
Cancer Research Communications|November 30, 2023
SHP2 Inhibition with TNO155 Increases Efficacy and Overcomes Resistance of ALK Inhibitors in NeuroblastomaIvette Valencia-Sama, Lynn Kee, Gabriella Christopher, et al.
Pageof 102